|
|||||
|
|
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity |
|
| Authors: | Ying Z. Mazzu,YuRou Liao,Subhiksha Nandakumar,Martin Sjö strö m,Lina E. Jehane,Romina Ghale,Barani Govindarajan,Travis A. Gerke,Gwo‐ Shu Mary Lee,Jian‐ Hua Luo,Sreenivasa R. Chinni,Lorelei A. Mucci,Felix Y. Feng,Philip W. Kantoff |
| Abstract: | |
| Keywords: | dasatinib, DNA methylation, HDAC inhibitor, prostate cancer, SNAI2, TMPRSS2‐ ERG |